吕万良研究团队揭示了一种新的雌激素受体阳性乳腺癌基因增强子
北京大学药学院 天然药物及仿生药物国家重点实验室
The research group of Prof. Wanliang Lu revealed a novel oncogenic enhancer of estrogen receptor-positive breast cancer
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
中国药学(英文版)
.
2022, (9): 723
-724
.
>
>